ENvue Medical (FRA:56R1) Cyclically Adjusted FCF per Share: €-2,037.38 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:56R1 ENvue Medical Inc FRA:56R1
37 GF Score
Price €6.20
GF Value €72.47
! 4 Warning Signs
View Full Analysis

What is ENvue Medical Cyclically Adjusted FCF per Share?

ENvue Medical FRA:56R1 37 Cyclically Adjusted FCF per Share is €-2,037.38 as of Mar. 2026. GuruFocus rates FRA:56R1 with a GF Score™ of 37/100 and a GF Value™ of €72.47. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

ENvue Medical's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-1.139. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-2,037.38 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of ENvue Medical was 7.10% per year. The lowest was 7.10% per year. And the median was 7.10% per year.

As of today (2026-08-19), ENvue Medical's current stock price is €6.20. ENvue Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-2,037.38. ENvue Medical's Cyclically Adjusted Price-to-FCF of today is .


ENvue Medical  (FRA:56R1) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


ENvue Medical Cyclically Adjusted FCF per Share Related Terms


ENvue Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for ENvue Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENvue Medical Cyclically Adjusted FCF per Share Chart

ENvue Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -86.02 -443.16 -789.76 -2,127.00

ENvue Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,457.59 -749.41 -901.58 -2,127.00 -2,037.38

FRA:56R1 vs BTCY, VYCO, ADMT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, ENvue Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ENvue Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ENvue Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where ENvue Medical's Cyclically Adjusted Price-to-FCF falls into.


FRA:56R1
37GF Score
ENvue Medical Inc FRA:56R1
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENvue Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ENvue Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.139/330.2130*330.2130
=-1.139

Current CPI (Mar. 2026) = 330.2130.

ENvue Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -213.000 241.018 -291.826
201609 -119.000 241.428 -162.762
201612 -202.000 241.432 -276.281
201703 -189.500 243.801 -256.666
201706 -228.500 244.955 -308.031
201709 -202.500 246.819 -270.920
201712 -219.667 246.524 -294.239
201803 -235.000 249.554 -310.955
201806 -287.667 251.989 -376.966
201809 -228.667 252.439 -299.117
201812 -258.000 251.233 -339.107
201903 -276.333 254.202 -358.962
201906 -233.667 256.143 -301.238
201909 -337.000 256.759 -433.409
201912 -309.667 256.974 -397.924
202003 -270.000 258.115 -345.418
202006 -143.000 257.797 -183.169
202009 -147.500 260.280 -187.131
202012 -108.300 260.474 -137.296
202103 -73.000 264.877 -91.007
202106 -144.545 271.696 -175.677
202109 -45.000 274.310 -54.171
202112 -63.667 278.802 -75.407
202203 -121.615 287.504 -139.681
202206 -145.462 296.311 -162.105
202209 -152.615 296.808 -169.791
202212 -96.615 296.797 -107.493
202303 -74.800 301.836 -81.832
202306 -75.600 305.109 -81.820
202309 -39.938 307.789 -42.848
202312 -25.000 306.746 -26.913
202403 -21.360 312.332 -22.583
202406 -20.640 314.175 -21.694
202409 -30.120 315.301 -31.545
202412 -15.382 315.605 -16.094
202503 -19.794 319.799 -20.439
202506 -61.167 322.561 -62.618
202509 -1.984 324.800 -2.017
202512 -2.095 324.054 -2.135
202603 -1.139 330.213 -1.139

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-2,037.38 mean?
ENvue Medical (FRA:56R1) has a Cyclically Adjusted FCF per Share of €-2,037.38 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on ENvue Medical and its competitors.
Is ENvue Medical's Cyclically Adjusted FCF per Share too high?
ENvue Medical's current Cyclically Adjusted FCF per Share is €-2,037.38. Overall, ENvue Medical has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does ENvue Medical's Cyclically Adjusted FCF per Share compare to BTCY and VYCO?
ENvue Medical's Cyclically Adjusted FCF per Share of €-2,037.38 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on ENvue Medical and its competitors. ENvue Medical's current Cyclically Adjusted FCF per Share is €-2,037.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENvue Medical stock overvalued right now?
ENvue Medical (FRA:56R1) has a current Cyclically Adjusted FCF per Share of €-2,037.38. The stock's GF Value™ is €72.47, compared to a current price of €6.20 — trading 91.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-2,037.38. ENvue Medical's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For ENvue Medical (FRA:56R1), the current Cyclically Adjusted FCF per Share is €-2,037.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ENvue Medical (FRA:56R1) Overvalued in 2026?

Based on GuruFocus' analysis, ENvue Medical stock appears to be undervalued. The current stock price of €6.20 is trading 91.4% below its estimated GF Value™ of €72.47.

Key valuation signals for FRA:56R1:

  • Cyclically Adjusted FCF per Share: €-2,037.38
  • GF Value™: €72.47 vs. price of €6.20 (91.4% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the FRA:56R1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ENvue Medical Business Description

Other Exchanges FEED:USA
Address 969 Pruitt Avenue, Tyler, TX, USA, 77569
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
37GF Score

Get the complete analysis for FRA:56R1

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.20
Price
€72.47
GF Value